Polar Asset Management Partners Inc. Rapt Therapeutics, Inc. Transaction History

Polar Asset Management Partners Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$6.87 - $26.45 $319,455 - $1.23 Million	46,500 New	46,500 $417,000
Q4 2023 Feb 14, 2024	SELL	$11.28 - $25.46 $3.1 Million - $7.01 Million	-275,200 Reduced 58.65%	194,000 $4.82 Million
Q3 2023 Nov 14, 2023	BUY	$16.34 - $24.66 $1.02 Million - $1.54 Million	62,400 Added 15.34%	469,200 $7.8 Million
Q2 2023 Aug 14, 2023	BUY	$16.06 - $21.61 $1.46 Million - $1.96 Million	90,900 Added 28.77%	406,800 $7.61 Million
Q1 2023 May 15, 2023	BUY	$17.19 - $30.8 $5.43 Million - $9.73 Million	315,900 New	315,900 $5.8 Million

105

27.1M

26.7K

2.4K

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $36.2M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

Stay updated on Polar Asset Management Partners Inc. with notifications on news.